Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F E Strachan

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
American Journal of Hypertension|June 2, 1998
Clinical experience with endothelin antagonistsD J Webb, F E Strachan
Journal of Cardiovascular Pharmacology|January 1, 1995
Endothelium-dependent modulation of venoconstriction to sarafotoxin S6c in human veins in vivoF E Strachan, W G Haynes, D J Webb
QJM : Monthly Journal of the Association of Physicians|February 28, 2002
Abnormal endothelin B receptor vasomotor responses in patients with Hirschsprung's diseaseD E Newby, F E Strachan, D J Webb
Circulation|August 1, 1995
Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivoW G Haynes, F E Strachan, D J Webb
QJM : Monthly Journal of the Association of Physicians|March 26, 2021
Predictors of UK healthcare worker burnout during the COVID-19 pandemicA V Ferry, R Wereski, F E Strachan, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humansW G Haynes, F E Strachan, G A Gray, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humansS Masumori, D E Newby, F E Strachan, et al.
British Journal of Clinical Pharmacology|July 25, 2000
Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivoF E Strachan, T R Crockett, N L Mills, et al.
British Journal of Pharmacology|October 6, 2001
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy menJ C Spratt, J Goddard, N Patel, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Hypertension|June 2, 1998
Clinical experience with endothelin antagonistsD J Webb, F E Strachan
Journal of Cardiovascular Pharmacology|January 1, 1995
Endothelium-dependent modulation of venoconstriction to sarafotoxin S6c in human veins in vivoF E Strachan, W G Haynes, D J Webb
QJM : Monthly Journal of the Association of Physicians|February 28, 2002
Abnormal endothelin B receptor vasomotor responses in patients with Hirschsprung's diseaseD E Newby, F E Strachan, D J Webb
Circulation|August 1, 1995
Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivoW G Haynes, F E Strachan, D J Webb
QJM : Monthly Journal of the Association of Physicians|March 26, 2021
Predictors of UK healthcare worker burnout during the COVID-19 pandemicA V Ferry, R Wereski, F E Strachan, et al.
Journal of Cardiovascular Pharmacology|January 1, 1995
Forearm vasoconstriction to endothelin-1 is mediated by ETA and ETB receptors in vivo in humansW G Haynes, F E Strachan, G A Gray, et al.
Clinical Pharmacology and Therapeutics|August 17, 2000
Big endothelin-3 constricts forearm resistance vessels but not hand veins in humansC J Ferro, F E Strachan, E Shepherd, et al.
Clinical Pharmacology and Therapeutics|October 23, 1997
Endogenous angiotensin II does not contribute to sympathetic venoconstriction in dorsal hand veins of healthy humansS Masumori, D E Newby, F E Strachan, et al.
British Journal of Clinical Pharmacology|July 25, 2000
Constriction to ETB receptor agonists, BQ-3020 and sarafotoxin s6c, in human resistance and capacitance vessels in vivoF E Strachan, T R Crockett, N L Mills, et al.
British Journal of Pharmacology|October 6, 2001
Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy menJ C Spratt, J Goddard, N Patel, et al.
Pageof 2